BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7662962)

  • 1. A novel single-cell proliferation assay shows that long-term culture-initiating cell (LTC-IC) maintenance over time results from the extensive proliferation of a small fraction of LTC-IC.
    Verfaillie CM; Miller JS
    Blood; 1995 Sep; 86(6):2137-45. PubMed ID: 7662962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primitive long-term culture initiating cells (LTC-ICs) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICs in steady state bone marrow.
    Prosper F; Vanoverbeke K; Stroncek D; Verfaillie CM
    Blood; 1997 Jun; 89(11):3991-7. PubMed ID: 9166837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct contact with stroma inhibits proliferation of human long-term culture initiating cells.
    Verfaillie CM; Catanzaro P
    Leukemia; 1996 Mar; 10(3):498-504. PubMed ID: 8642869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells.
    Verfaillie CM; Miller JS
    Blood; 1994 Sep; 84(5):1442-9. PubMed ID: 7520771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells.
    Gupta P; McCarthy JB; Verfaillie CM
    Blood; 1996 Apr; 87(8):3229-36. PubMed ID: 8605338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term culture-initiating cell expansion is dependent on frequent medium exchange combined with stromal and other accessory cell effects.
    Koller MR; Palsson MA; Manchel I; Palsson BO
    Blood; 1995 Sep; 86(5):1784-93. PubMed ID: 7544642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo culture of CD34+/Lin-/DR- cells in stroma-derived soluble factors, interleukin-3, and macrophage inflammatory protein-1alpha maintains not only myeloid but also lymphoid progenitors in a novel switch culture assay.
    Miller JS; McCullar V; Verfaillie CM
    Blood; 1998 Jun; 91(12):4516-22. PubMed ID: 9616147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
    Bhatia R; McGlave PB; Miller JS; Wissink S; Lin WN; Verfaillie CM
    Exp Hematol; 1997 Aug; 25(9):980-91. PubMed ID: 9257812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cells.
    Bennaceur-Griscelli A; Tourino C; Izac B; Vainchenker W; Coulombel L
    Blood; 1999 Jul; 94(2):529-38. PubMed ID: 10397720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal factors support the expansion of the whole hemopoietic spectrum from bone marrow CD34+DR- cells and of some hemopoietic subsets from CD34+ and CD34+DR+ cells.
    Herman P; Ferrant A; De Bruyère M; Straetmans N
    Leukemia; 1998 May; 12(5):735-45. PubMed ID: 9593272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct contact between CD34+lin- cells and stroma induces a soluble activity that specifically increases primitive hematopoietic cell production.
    Koller MR; Oxender M; Jensen TC; Goltry KL; Smith AK
    Exp Hematol; 1999 Apr; 27(4):734-41. PubMed ID: 10210331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor.
    Prosper F; Stroncek D; Verfaillie CM
    Blood; 1996 Sep; 88(6):2033-42. PubMed ID: 8822922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant erythropoietin in interaction with stromal factors on cord blood hematopoiesis.
    Abe T; Takaue Y; Kawano Y; Kuroda Y
    Blood; 1996 Apr; 87(8):3212-7. PubMed ID: 8605336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can human hematopoietic stem cells be cultured ex vivo?
    Verfaillie CM
    Stem Cells; 1994 Sep; 12(5):466-76. PubMed ID: 7528589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis.
    Traycoff CM; Kosak ST; Grigsby S; Srour EF
    Blood; 1995 Apr; 85(8):2059-68. PubMed ID: 7536490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation.
    Verfaillie CM
    Blood; 1993 Oct; 82(7):2045-53. PubMed ID: 7691246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium.
    Petzer AL; Hogge DE; Landsdorp PM; Reid DS; Eaves CJ
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1470-4. PubMed ID: 8643656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrocortisone differentially affects the ability of murine stromal cells and human marrow-derived adherent cells to promote the differentiation of CD34++/CD38- long-term culture-initiating cells.
    Croisille L; Auffray I; Katz A; Izac B; Vainchenker W; Coulombel L
    Blood; 1994 Dec; 84(12):4116-24. PubMed ID: 7527666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The type of stromal feeder used in limiting dilution assays influences frequency and maintenance assessment of human long-term culture initiating cells.
    Punzel M; Moore KA; Lemischka IR; Verfaillie CM
    Leukemia; 1999 Jan; 13(1):92-7. PubMed ID: 10049066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo expansion of long-term culture initiating marrow cells by IL-10, SCF, and IL-3.
    Keil F; Elahi F; Greinix HT; Fritsch G; Louda N; Petzer AL; Prinz E; Wagner T; Kalhs P; Lechner K; Geissler K
    Transfusion; 2002 May; 42(5):581-7. PubMed ID: 12084166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.